G1P3, an interferon- and estrogen-induced survival protein contributes to hyperplasia, tamoxifen resistance and poor outcomes in breast cancer
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
G1P3, an interferon- and estrogen-induced survival protein contributes to hyperplasia, tamoxifen resistance and poor outcomes in breast cancer
Authors
Keywords
-
Journal
ONCOGENE
Volume 31, Issue 17, Pages 2222-2236
Publisher
Springer Nature
Online
2011-10-17
DOI
10.1038/onc.2011.393
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- L’entose, mort cellulaire par cannibalisme entre cellules tumorales
- (2011) Arnaud A. Mailleux et al. M S-MEDECINE SCIENCES
- BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received
- (2010) S-J Dawson et al. BRITISH JOURNAL OF CANCER
- Lumen formation during mammary epithelial morphogenesis: insights from in vitro and in vivo models
- (2010) Arnaud A. Mailleux et al. CELL CYCLE
- Mechanisms of resistance to hormonal treatment in breast cancer
- (2010) Pilar Eroles et al. Clinical & Translational Oncology
- Hyperactivation of phosphatidylinositol-3 kinase promotes escape from hormone dependence in estrogen receptor–positive human breast cancer
- (2010) Todd W. Miller et al. JOURNAL OF CLINICAL INVESTIGATION
- Emerging Roles of FAM14 Family Members (G1P3/ISG 6–16 and ISG12/IFI27) in Innate Immunity and Cancer
- (2010) Venugopalan Cheriyath et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Combinations of DNA Methyltransferase and Histone Deacetylase Inhibitors Induce DNA Damage in Small Cell Lung Cancer Cells: Correlation of Resistance with IFN-Stimulated Gene Expression
- (2010) Wioleta Luszczek et al. MOLECULAR CANCER THERAPEUTICS
- Meta-analysis confirms BCL2 is an independent prognostic marker in breast cancer
- (2009) Grace M Callagy et al. BMC CANCER
- Proliferative genes dominate malignancy-risk gene signature in histologically-normal breast tissue
- (2009) Dung-Tsa Chen et al. BREAST CANCER RESEARCH AND TREATMENT
- Overcoming Drug Resistance by Enhancing Apoptosis of Tumor Cells
- (2009) Pepita Gimenez-Bonafe et al. CURRENT CANCER DRUG TARGETS
- A methodology for the combined in situ analyses of the precursor and mature forms of microRNAs and correlation with their putative targets
- (2009) Gerard J Nuovo et al. Nature Protocols
- BAG-1 overexpression attenuates luminal apoptosis in MCF-10A mammary epithelial cells through enhanced RAF-1 activation
- (2009) L R Anderson et al. ONCOGENE
- Modeling Morphogenesis and Oncogenesis in Three-Dimensional Breast Epithelial Cultures
- (2008) Christy Hebner et al. Annual Review of Pathology-Mechanisms of Disease
- Transcriptomic dissection of tongue squamous cell carcinoma
- (2008) Hui Ye et al. BMC GENOMICS
- Epithelial Progeny of Estrogen-Exposed Breast Progenitor Cells Display a Cancer-like Methylome
- (2008) A. S.L. Cheng et al. CANCER RESEARCH
- Molecular Profile of theBCL2Family of the Apoptosis Related Genes in Breast Cancer Cells after Treatment with Cytotoxic/Cytostatic Drugs
- (2008) Hellinida Thomadaki et al. CONNECTIVE TISSUE RESEARCH
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
- An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer
- (2008) R. R. Weichselbaum et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Unraveling the microenvironmental influences on the normal mammary gland and breast cancer
- (2008) Britta Weigelt et al. SEMINARS IN CANCER BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started